On Tuesday, Jan. 10, Global Healthcare will become Reuters Health Rounds, a newsletter curated by Nancy Lapid, editor in charge of Reuters Health. Reuters Health Rounds will be sent on Tuesdays and Thursdays.
China is in talks with Pfizer to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in the country, sources say.
China on Saturday marked the first day of "chun yun", the 40-day period of Lunar New Year travel known pre-pandemic as the world's largest annual migration of people, bracing for a huge increase in travellers and the spread of COVID-19 infections.
Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and Drug Administration for a standard review of its Alzheimer's drug Leqembi, which was recently approved under the agency's accelerated review process.
China reported three new COVID-19 deaths in the mainland for Jan. 6, compared with five deaths a day earlier, the Chinese Center for Disease Control and Prevention said on Saturday.
China's CanSino Biologics Inc has entered "test production phase" for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday.
Portugal will require air travellers from China to show proof of a negative COVID-19 test done no more than two days before departure, the health ministry said on Friday, following other nations that have implemented such restrictions.
The U.S. Food and Drug Administration on Friday approved Eisai Co Ltd and Biogen Inc's Alzheimer's drug lecanemab for the treatment of early forms of the fatal, brain-wasting disease.
Prime Minister Rishi Sunak will on Saturday meet leaders of England's health service, as it faces one of its toughest ever winters as flu and COVID-19 spread amid strike action by frontline staff who say high inflation has eroded their salaries.
The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca's COVID-19 antibody cocktail Evusheld to provide protection against the Omicron subvariant XBB.1.5.
Pharmacies across the United States are weighing whether to sell mifepristone, a pill used in medication abortions, following the Food and Drug Administration's announcement earlier this week that they can now do so.
